Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,088 recruiting studies in this area right now.
By phase
- Not applicable4,195
- Phase 2595
- Phase 1411
- Phase 3325
- Phase 4251
- Phase 1/Phase 2245
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer336
- Cervical Cancer223
- Endometrial Cancer207
- Bladder Cancer187
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer111
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California349
- Alabama153
- Texas120
- Massachusetts118
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,088 total
- NCT06804538Recruiting
Comparing insemination timing 42 vs 36 hours after hCG injection
This trial tests whether waiting 42 hours after a hormone injection (hCG) before performing intrauterine insemination (IUI) leads to better pregnancy results than the standard 36-hour wait. It is for women or couples who are doing their first or second IUI and whose fallopian tubes are open.
BordeauxAges 18–43 - NCT06809582Recruiting
Body position and kidney stone removal results
This study looks at how your body’s position during surgery affects how well kidney stones are cleared. If you have stones ≤2 cm and are having a scope-based kidney stone removal, you may be able to join.
SamsunAges 18 years+ - NCT06808516RecruitingPhase 2
Can oxytocin spray improve sex life in people with AVP deficiency?
This study tests whether a nasal spray containing oxytocin can improve sexual well-being in people with a condition called arginine vasopressin deficiency (a problem with a hormone that controls water balance). Healthy volunteers who have mild sexual issues will also take part for comparison. Participants receive either the oxytocin spray or a placebo and fill out questionnaires about their sex life.
BaselAges 18 years+ - NCT06803992RecruitingPhase 4
Comparing methods to start labor at full term
This study compares two common methods for starting labor — a vaginal insert (Propess) and a gel or balloon catheter. The goal is to find the safest and most effective way to start labor at full term.
AfulaAges 18–60 - NCT06812507Recruiting
Umbilical cord blood transfer in very premature babies
This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.
AlexandriaAges 1 minute–2 minutes - NCT06810622Recruiting
NAVIGATE Kidney: Reducing Kidney Health Disparities
This study is testing a program called NAVIGATE Kidney that aims to improve kidney health and reduce racial or ethnic gaps in care. It is for adults with advanced kidney disease (eGFR 15-29) who are not yet on dialysis or had a transplant, and it involves education and support to help manage their condition.
Denver, ColoradoAges 18–75 - NCT06807749Recruiting
Adjuvant treatment for premenopausal breast cancer
This trial looks back at premenopausal women with early-stage, hormone-positive, HER2-negative breast cancer who had surgery and an Oncotype DX test, to see how different treatments affected their outcomes. If you fit this group, your past medical records could help researchers learn more about the best treatments.
Roma, Antonella PalazzoAges Up to 60 years - NCT06807203Recruiting
Baby voice and movement study in the NICU
This study observes how babies born early or full-term move and make sounds in the hospital. It may help doctors understand early development better.
Columbus, OhioAges Up to 1 week - NCT06814496RecruitingPhase 1/Phase 2
Radiation and immunotherapy combo for DLL3-positive cancers
This trial combines radiation with an immunotherapy drug called tarlatamab to treat cancers that make a protein called DLL3. The goal is to see if this combination works better than either treatment alone for people with certain types of lung cancer and other tumors that have not responded to prior therapy.
Gilbert, ArizonaAges 18–99 - NCT06810895Enrolling by invitation
Immunotherapy plus chemo for recurrent cervical cancer
This trial tests a new immunotherapy drug called cadonilimab (AK104) combined with standard chemotherapy for women whose small cell neuroendocrine cervical cancer has returned or spread. The goal is to see if this combination helps shrink tumors or slow the cancer better than chemotherapy alone.
WuhanAges 18–75 - NCT06810739Recruiting
Women's Screening and Self-Testing Program (PROMETA)
This study tests a self-screening program for cervical cancer among women who are already receiving HIV care. It aims to make screening easier and more accessible.
MaputoAges 25–49 - NCT06814509Recruiting
HOPE program for pregnant women
This study tests a program called HOPE that helps pregnant women get the support they need for a healthy pregnancy. It is designed to make prenatal care more fair and accessible.
Corning, ArkansasAges 16–44 - NCT05012072Recruiting
Lifestyle coaching to lower pregnancy stress and risk
This study tests a lifestyle coaching program to help reduce stress and improve emotional wellbeing during pregnancy. It may help lower risks for the baby by supporting healthier daily routines and mental health.
Webster, TexasAges 18–45 - NCT05635123Recruiting
Study of newly diagnosed cervical or endometrial cancer
This study follows women who are newly diagnosed with cervical or endometrial (uterine lining) cancer at a health check-up. It helps doctors learn more about these cancers and how they behave, which may improve future care.
Hangzhou, ZhejiangAges 20–75 - NCT06019923Recruiting
Metabolic biomarkers study in newly diagnosed ovarian cancer
This study looks at certain substances in the body (called metabolic biomarkers) and how they relate to how well patients do after treatment. It is for women who have just been diagnosed with high-grade serous ovarian cancer and have not yet had any treatment.
Hangzhou, ZhejiangAges 18–75 - NCT06795074RecruitingPhase 4
Comparing coated vs non-coated balloons for recurring urethral stricture
This trial tests if a balloon coated with a drug (paclitaxel) helps prevent the urethra from narrowing again after treatment. It may be an option for people whose stricture has come back after a prior procedure.
GothenburgAges 18 years+ - NCT06800313RecruitingPhase 1/Phase 2
A study of HLD-0915 for metastatic prostate cancer
This trial tests a new drug called HLD-0915 in men with prostate cancer that has spread. It aims to see how well the drug works and if it's safe.
Colorado Springs, ColoradoAges 18 years+ - NCT06800963RecruitingPhase 1/Phase 2
A new BCG treatment for bladder cancer that hasn't spread
This trial tests a new form of intravesical (given directly into the bladder) treatment called rMBCG for people with non-muscle invasive bladder cancer who have not had BCG therapy before. It may be an option for those with certain types of early bladder cancer, including carcinoma in situ (CIS) or papillary tumors after removal surgery.
Chandler, ArizonaAges 18–85 - NCT06798207RecruitingPhase 2
TQB2102 for advanced gynecologic cancers with HER2
This trial tests a new targeted drug, TQB2102, for women with advanced or recurrent gynecologic cancers that have some HER2 protein. It may be an option if your cancer has continued to grow after platinum chemotherapy.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06797518RecruitingPhase 2
Testing iptacopan for IgA nephropathy kidney changes
This study tests if adding iptacopan to standard care can improve kidney health in adults with IgA nephropathy. You may qualify if you have a kidney biopsy confirming IgA nephropathy and your kidney function is stable enough.
Birmingham, AlabamaAges 18–99 - NCT06799637RecruitingPhase 1/Phase 2
Study of XNW28012 for advanced solid tumors
This trial tests a new drug called XNW28012 for people with advanced solid tumors that have not responded to or caused side effects from standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
Hefei, AnhuiAges 18 years+ - NCT06799065RecruitingPhase 1/Phase 2
Oral drug for advanced solid tumors including ovarian cancer
This trial tests a new daily pill that targets a protein helping cancer cells divide. It may stop tumors from growing in people with advanced or metastatic cancer that has returned or stopped responding to standard treatments, including some types of ovarian, lung, and other solid tumors.
Aurora, ColoradoAges 18 years+ - NCT06615102RecruitingPhase 3
Testing if angiotensin II prevents kidney injury after heart surgery
This trial tests whether giving a medicine called angiotensin II during heart surgery can help prevent acute kidney injury (a sudden drop in kidney function). It is for adults having certain types of heart surgery who have a higher risk of kidney problems.
BerlinAges 18 years+ - NCT06799507Recruiting
Mindfulness program for women with infertility
This trial tests whether a mindfulness-based support program can help women going through IVF. If you have primary infertility (never been pregnant) and are about to start IVF, this program might reduce stress and improve your well-being.
Izmir, İzmirAges 18–45
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,088 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,891 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.